• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Design Therapeutics Inc (NQ: DSGN )

    3.250 -0.100 (-2.99%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 166,612
    Open 3.320
    Bid (Size) 3.250 (15)
    Ask (Size) 3.270 (5)
    Prev. Close 3.350
    Today's Range 3.210 - 3.350
    52wk Range 1.940 - 8.310
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them. 
    Via InvestorPlace
    DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024
    DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +27.95%
    +27.95%
    1 Month
    -20.15%
    -20.15%
    3 Month
    -19.15%
    -19.15%
    6 Month
    +27.95%
    +27.95%
    1 Year
    -49.69%
    -49.69%

    More News

    Read More
    Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Preview For Design Therapeutics
    Via Benzinga
    Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 19, 2024
    Via Benzinga
    Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
    Via Benzinga
    Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Shares of Design Therapeutics Are Plummeting on Tuesday
    Via The Motley Fool
    Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
    Via Benzinga
    Dow Falls Over 200 Points; US Retail Sales Top Expectations
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Is Design Therapeutics Stock Moving Lower Today?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.